美国 · SEC FORM 4
Korro Bio, Inc.
KRRO · Nasdaq · CIK 0001703647 · Healthcare · Biotechnology
内部人信号
2 qualifying P purchase groups
当前 180 天评分窗口
40 同一窗口内观察到的 Form 4 交易行
33 sales · 5 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度与集中度
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-08-10 · Lynx1 Capital Management LP; Nichols Weston.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 1,675,219
- 上期报告
- 1,551,984
- 日均成交量
- 255,628
- 回补天数
- 6.5
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Lynx1 Capital Management LP; Nichols Weston | 买入 (P) | Common stock, $0.001 par value per share | 1,462 | USD 13.19 | USD 19,284 | SEC 申报 ↗ |
| 2026-08-06 | Lynx1 Capital Management LP; Nichols Weston | 买入 (P) | Common stock, $0.001 par value per share | 5,222 | USD 11.40 | USD 59,531 | SEC 申报 ↗ |
| 2026-03-10 | Yang Rick | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | Walker Paul Edward | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | SANDELL SCOTT D | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | Mathers Edward T | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | Makhzoumi Mohamad | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | Florence Anthony A. Jr. | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | Chang Carmen | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | BASKETT FOREST | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2024-04-22 | Yang Rick | 买入 (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC 申报 ↗ |
| 2024-04-22 | Walker Paul Edward | 买入 (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC 申报 ↗ |
| 2024-04-22 | SANDELL SCOTT D | 买入 (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC 申报 ↗ |
| 2024-04-22 | NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | 买入 (P) | Common Stock | 17,857 | USD 56.00 | USD 999,992 | SEC 申报 ↗ |
Form 4 申报证据
55 transaction lines in the latest 365-day window; 392 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 38,490 | USD 14.12 | USD 543,479 | SEC 申报 ↗ |
| 2026-09-11 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 10,200 | USD 13.99 | USD 142,698 | SEC 申报 ↗ |
| 2026-09-11 | Dolan Oliver | 卖出 (S) | Common Stock | 5 | USD 13.72 | USD 69 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 38,490 | USD 14.12 | USD 543,479 | SEC 申报 ↗ |
| 2026-09-11 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 10,200 | USD 13.99 | USD 142,698 | SEC 申报 ↗ |
| 2026-09-11 | Dolan Oliver | 卖出 (S) | Common Stock | 5 | USD 13.72 | USD 69 | SEC 申报 ↗ |
| 2026-09-09 | Dolan Oliver | 卖出 (S) | Common Stock | 6 | USD 13.60 | USD 82 | SEC 申报 ↗ |
| 2026-09-08 | Dolan Oliver | 卖出 (S) | Common Stock | 7,347 | USD 13.51 | USD 99,258 | SEC 申报 ↗ |
| 2026-08-26 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 300 | USD 13.96 | USD 4,188 | SEC 申报 ↗ |
| 2026-08-19 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 28,468 | USD 14.00 | USD 398,552 | SEC 申报 ↗ |
| 2026-08-11 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 2,143 | USD 13.96 | USD 29,916 | SEC 申报 ↗ |
| 2026-08-10 | Lynx1 Capital Management LP; Nichols Weston | 买入 (P) | Common stock, $0.001 par value per share | 1,462 | USD 13.19 | USD 19,284 | SEC 申报 ↗ |
| 2026-08-06 | Lynx1 Capital Management LP; Nichols Weston | 买入 (P) | Common stock, $0.001 par value per share | 5,222 | USD 11.40 | USD 59,531 | SEC 申报 ↗ |
| 2026-08-04 | Aiyar Ram | 卖出 (S) | Common Stock | 5,802 | USD 10.84 | USD 62,894 | SEC 申报 ↗ |
| 2026-07-15 | Vincent Loic A | 奖励/授予 (A) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Dolan Oliver | 奖励/授予 (A) | Common Stock | 5,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Chappell Todd | 奖励/授予 (A) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Cerio Jeffrey | 奖励/授予 (A) | Common Stock | 6,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-06 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 9,323 | USD 13.96 | USD 130,149 | SEC 申报 ↗ |
| 2026-07-02 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 100,700 | USD 14.03 | USD 1,412,821 | SEC 申报 ↗ |
| 2026-06-24 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 48,438 | USD 14.61 | USD 707,491 | SEC 申报 ↗ |
| 2026-06-23 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 119,005 | USD 14.25 | USD 1,695,821 | SEC 申报 ↗ |
| 2026-06-22 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 3,962 | USD 13.95 | USD 55,270 | SEC 申报 ↗ |
| 2026-06-16 | Vincent Loic A | 卖出 (S) | Common Stock | 3,418 | USD 10.83 | USD 37,017 | SEC 申报 ↗ |
| 2026-06-16 | Dolan Oliver | 卖出 (S) | Common Stock | 3,383 | USD 10.83 | USD 36,638 | SEC 申报 ↗ |
| 2026-06-16 | Chappell Todd | 卖出 (S) | Common Stock | 3,168 | USD 10.83 | USD 34,309 | SEC 申报 ↗ |
| 2026-06-16 | Cerio Jeffrey | 卖出 (S) | Common Stock | 6,609 | USD 10.83 | USD 71,575 | SEC 申报 ↗ |
| 2026-05-29 | Aiyar Ram | 卖出 (S) | Common Stock | 15,152 | USD 12.98 | USD 196,673 | SEC 申报 ↗ |
| 2026-05-28 | FORMELA JEAN FRANCOIS | 卖出 (S) | Common Stock | 2,860 | USD 13.95 | USD 39,897 | SEC 申报 ↗ |
| 2026-05-26 | Aiyar Ram | 奖励/授予 (A) | Common Stock | 50,000 | USD 12.33 | USD 616,500 | SEC 申报 ↗ |
| 2026-03-10 | Yang Rick | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | Walker Paul Edward | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
| 2026-03-10 | SANDELL SCOTT D | 买入 (P) | Common Stock | 207,100 | USD 11.11 | USD 2,300,881 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | KRRO |
| CIK | 0001703647 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 392 transaction lines from 2020-01-30 to 2026-09-14 23 P purchase lines · 283 S sale lines · 86 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.